Work

Postexposure Prophylaxis Against Varicella Zoster Virus Infection Among Hematopoietic Stem Cell Transplant Recipients

Year: 2006

Type: article

Abstract: A comprehensive approach is essential to minimize the morbidity caused by varicella zoster virus (VZV) among hematopoietic stem cell transplant (HSCT) recipients. However, prophylactic regimens to prevent VZV infection among HSCT recipients are controversial and vary widely [1]. Recently published guidelines from a National Institutes of Health working group on criteria for clinical trials in chronic graft-versus-host disease (GVHD) included the recommendation that “if VZV-seronegative patients with chronic GVHD are exposed to varicella (primary or postvaccination illness), VZV Ig should be given within 96 hours” [2].

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2006.06.005

Authors: David M. Weinstock, Michael Boeckh, Kent A. Sepkowitz

Institutions: Memorial Sloan Kettering Cancer Center, Fred Hutch Cancer Center

Language: English

Topic: Herpesvirus Infections and Treatments

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650